MCID: END042
MIFTS: 78

Endometrial Carcinoma malady

Cancer diseases category

Summaries for Endometrial Carcinoma

About this section
Sources:
8Disease Ontology, 63Wikipedia, 46OMIM, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:63 Endometrial cancer is any of several types of malignancies that arise from the endometrium, or lining,... more...

MalaCards: Endometrial Carcinoma, also known as endometrial cancer, is related to adenocarcinoma and papillary carcinoma. An important gene associated with Endometrial Carcinoma is MSH3 (mutS homolog 3), and among its related pathways are Pathways in cancer and Endometrial cancer. The compounds progesterone and retinoic acid have been mentioned in the context of this disorder. Affiliated tissues include the tissue lining the uterus, uterus and lymph node, and related mouse phenotypes are cellular and tumorigenesis.

Disease Ontology:8 A endometrial cancer that is located in the tissue lining the uterus.

Description from OMIM:46 608089

Aliases & Classifications for Endometrial Carcinoma

About this section
Sources:
8Disease Ontology, 46OMIM, 44Novoseek, 60UMLS, 9diseasecard, 42NIH Rare Diseases, 22GTR, 10DISEASES, 34MeSH, 56SNOMED-CT, 39NCIt, 25ICD10
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases


Aliases & Descriptions:

endometrial carcinoma 8 46 44 60
endometrial cancer 9 42 22 46 10 44
endometrioid carcinoma of female reproductive system 8
carcinoma of the endometrium 8
carcinoma of endometrium 8
carcinoma, endometrioid 60
endometrioid carcinoma 8
carcinoma endometrioid 44


External Ids:

Disease Ontology8 DOID:2871
MeSH34 D018269
OMIM46 608089
NCIt39 C3769
ICD1025 C54.1

Related Diseases for Endometrial Carcinoma

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Endometrial Carcinoma family:

Endometrial Cancer, Familial

Diseases related to Endometrial Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 256)
idRelated DiseaseScoreTop Affiliating Genes
1adenocarcinoma30.8IFI27, CTNNB1, ARSH, PIK3CA, MLH1, MKI67
2papillary carcinoma30.7ESR1, PGR, CDH1, MKI67, IFI27
3endometriosis30.6ARSH, HOXA10, PGR, PTEN, ESR1
4transitional cell carcinoma30.4IFI27, MLH1, MKI67, CDH1
5lynch syndrome30.4MLH1, MLH3, KRAS, MSH3
6ovarian cancer30.3KLK4, IFI27, CTNNB1, PIK3CA, MLH1, CDH1
7colorectal cancer30.3IFI27, CTNNB1, PTEN, MSH3, KRAS, CDH1
8breast cancer30.3IFI27, CTNNB1, PIK3CA, CDH1, PGR, KRAS
9cervical adenocarcinoma30.3IFI27, CDKN2A, PGR, ESR1
10retinoblastoma30.2IFI27, PIK3CA, MKI67, CDKN2A, KRAS, ESR1
11cervical cancer30.2IFI27, PIK3CA, MLH1, CDKN2A, KRAS
12squamous cell carcinoma30.1MKI67, CDH1, MMP26
13pancreatic cancer30.1IFI27, CTNNB1, ARSH, PIK3CA, MLH1, ANG
14endometrial carcinoma, somatic30.1CDH1, PTEN
15myoma30.1PGR, ESR1
16adenocarcinoma in situ30.1CDKN2A
17leiomyoma30.1ESR1, PGR, MKI67
18infertility30.1ESR1, HOXA10
19pancreatitis30.1KRAS
20cystadenoma30.0KRAS
21colon cancer29.9CTNNB1, PIK3CA, MLH1, CDH1, KRAS, TDGF1P3
22lung cancer29.9PIK3CA, CDKN2A, CDH1, KRAS, PTEN
23melanoma29.9IFI27, CTNNB1, PIK3CA, MLH1, ANG, MKI67
24sarcoma29.9MLH1, MKI67, KRAS
25tuberous sclerosis29.9PTEN, PIK3CA, IFI27
26inflammatory breast carcinoma29.9ESR1, PGR, CDH1
27papilloma29.9CDKN2A, IFI27
28prolactinoma29.9ESR1
29prostate cancer29.9IFI27, CTNNB1, MKI67, CDH1, MMP26, PTEN
30endometrial stromal sarcoma29.9PGR, ESR1
31thyroid cancer29.9PTEN, CDH1, PIK3CA, IFI27
32small cell carcinoma10.7
33cervicitis10.6
34neuroendocrine carcinoma10.5
35lymph node cancer10.5
36endometrial adenocarcinoma10.5
37vascular cancer10.4
38verrucous carcinoma10.4
39large cell carcinoma10.4
40peritonitis10.4
41vaginitis10.4
42in situ carcinoma10.3
43ovarian brenner tumor10.3
44lymphoepithelioma-like carcinoma10.3
45endometrial transitional cell carcinoma10.3
46obesity10.3
47ovarian endometriosis10.3
48ovarian endometrioid neoplasm10.3
49uterine inversion10.2
50bone carcinoma10.2

Graphical network of the top 20 diseases related to Endometrial Carcinoma:



Diseases related to endometrial carcinoma

Clinical Features for Endometrial Carcinoma

About this section
Sources:
46OMIM
See all sources

Clinical features from OMIM:

608089

Drugs & Therapeutics for Endometrial Carcinoma

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Endometrial Carcinoma

Drug clinical trials:

Search ClinicalTrials for Endometrial Carcinoma

Search NIH Clinical Center for Endometrial Carcinoma

Search CenterWatch for Endometrial Carcinoma

Genetic Tests for Endometrial Carcinoma

About this section
Sources:
22GTR
See all sources

Genetic tests related to Endometrial Carcinoma:

id Genetic test Affiliating Genes
1 Endometrial Carcinoma22

Anatomical Context for Endometrial Carcinoma

About this section
Sources:
32MalaCards, 14FMA
See all sources

MalaCards organs/tissues related to Endometrial Carcinoma:

32
Uterus, Lymph node, Breast, Endothelial, Ovary, Cervix, Colon, Testes, T cells, Bone, Testis, Pituitary, Lung, Small intestine, Retina, Brain, Tongue

FMA organs/tissues related to Endometrial Carcinoma:

14
The tissue lining the uterus

Animal Models for Endometrial Carcinoma or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Endometrial Carcinoma:

36 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538412.0CTNNB1, PIK3CA, MLH1, CDKN2A, CDH1, PGR
2MP:000200612.0ESR1, CTNNB1, PIK3CA, MLH1, CDKN2A, CDH1
3MP:001076811.8MLH1, PIK3CA, CTNNB1, KLK4, CDKN2A, CDH1
4MP:000538911.7CTNNB1, PIK3CA, MLH1, MLH3, CDKN2A, CDH1
5MP:000537811.7KLK4, CTNNB1, PIK3CA, CDKN2A, CDH1, HOXA10
6MP:000538111.7CTNNB1, MLH1, CDKN2A, CDH1, HOXA10, KRAS
7MP:001077111.6CTNNB1, PIK3CA, CDKN2A, CDH1, KRAS, MSH3
8MP:000537911.5PIK3CA, MLH1, MLH3, CDKN2A, HOXA10, KRAS
9MP:000537611.5KLK4, PIK3CA, PGR, MSH3, ESRRA, ESR1
10MP:000538711.3CTNNB1, PIK3CA, CDKN2A, CDH1, PGR, KRAS
11MP:000539010.9ESRRA, PGR, HOXA10
12MP:000536910.8CDKN2A, ESR1
13MP:000538010.8PGR
14MP:000537110.7HOXA10

Publications for Endometrial Carcinoma

About this section
Sources:
50PubMed
See all sources

Articles related to Endometrial Carcinoma:

(show top 50)    (show all 1342)
idTitleAuthorsYear
1
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. (22944067)
2013
2
Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma. (24386010)
2013
3
TIF1I^-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody. (23407650)
2013
4
Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma. (23206584)
2013
5
Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway. (23142288)
2013
6
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. (21435442)
2011
7
Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. (21190977)
2011
8
Single nucleotide polymorphism in DNA base excision repair genes XRCC1 and hOGG1 and the risk of endometrial carcinoma in the Polish population. (21866464)
2011
9
Adult granulosa cell tumor associated with endometrial carcinoma: a case report. (21810262)
2011
10
Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens. (21543931)
2011
11
Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma. (20944158)
2010
12
STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone. (20668024)
2010
13
Peritumoral lymphatic vessel density as a prognostic parameter in endometrial carcinoma: an immunohistochemical study. (20699504)
2010
14
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. (20065186)
2010
15
mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues. (20661955)
2010
16
Staging of endometrial carcinoma by magnetic resonance imaging: correlation with surgery and histopathology. (19750859)
2009
17
Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression]. (20079181)
2009
18
A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer. (19758691)
2009
19
Criteria for evaluating the effectiveness of aromatase inhibitors in the neoadjuvant treatment of patients with endometrial carcinoma]. (19670731)
2009
20
An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study. (17945336)
2008
21
Differential expression of clusterin according to histological type of endometrial carcinoma. (18514801)
2008
22
Screening, cloning and identification of the human endometrial carcinoma-related genes]. (18210876)
2007
23
S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma. (16033094)
2005
24
Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma. (15741767)
2005
25
Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma. (15681469)
2005
26
A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. (15047211)
2004
27
Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series. (15361209)
2004
28
Diagnostic problems on frozen section examination of myometrial invasion in patients with endometrial carcinoma with special emphasis on the pitfalls of deep adenomyosis with carcinomatous involvement. (15032284)
2004
29
Inhibitory effect of tumor suppressor PTEN on cell growth of endometrial carcinoma]. (15312361)
2004
30
Detection of mutation and protein expression of PTEN gene in endometrial carcinoma]. (14720379)
2004
31
Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells. (12574212)
2003
32
Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. (12209724)
2002
33
Estradiol up-regulates estrogen receptor messenger ribonucleic acid in endometrial carcinoma (Ishikawa) cells by stabilizing the message. (12200234)
2002
34
Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. (11570574)
2001
35
The influence of hormones on CD44 expression in endometrial and breast carcinomas. (11496303)
2001
36
Application of mRNA differential display technique in screening related gene of endometrial carcinoma (11783137)
2001
37
Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma. (10739683)
2000
38
Cyclin D1 expression in high-grade endometrial carcinomas--association with histologic subtype. (11109161)
2000
39
Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. (10705818)
2000
40
The regulation of estrogen and tamoxifen to bcl-2 oncogene in endometrial carcinoma]. (11477803)
1999
41
A somatic BRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain. (10451700)
1999
42
MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. (9811473)
1998
43
Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome. (9577367)
1998
44
Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma. (9045318)
1997
45
Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma. (8626126)
1996
46
Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients. (8626110)
1996
47
Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. (8625242)
1996
48
Diamine-oxidase activity and tissue di- and poly-amine contents of human ovarian, cervical and endometrial carcinoma. (7882298)
1995
49
Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and "squamous differentiation" in human endometrial carcinoma. (7528164)
1994
50
Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma. (8092757)
1994

Genetic Variations for Endometrial Carcinoma

About this section
Sources:
62UniProtKB/Swiss-Prot
See all sources

Genetic disease variations for Endometrial Carcinoma:

62
id Symbol AA change Variation ID SNP ID
1PTENp.His123TyrVAR_026260

Expression for genes affiliated with Endometrial Carcinoma

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Endometrial Carcinoma

Search GEO for disease gene expression data for Endometrial Carcinoma.

Pathways for genes affiliated with Endometrial Carcinoma

About this section
Sources:
29KEGG, 12EMD Millipore, 37NCBI BioSystems Database, 53Reactome, 51QIAGEN
See all sources

Pathways related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
111.5CTNNB1, PIK3CA, MLH1, CDKN2A, CDH1, KRAS
2
Hide members
11.4PTEN, CTNNB1, PIK3CA, MLH1, CDH1, KRAS
3
Hide members
11.2CTNNB1, PIK3CA, CDH1, KRAS, PTEN, ESR1
411.1CTNNB1, CDH1, KRAS, PTEN, ESR1
5
Hide members
11.1PIK3CA, PGR, KRAS, PTEN, ESR1
611.1ESR1, PTEN, KRAS, PIK3CA, CTNNB1
7
Development Endothelin-1/EDNRA signaling
Hide members
11.1CTNNB1, PIK3CA, KRAS, PTEN, ESR1
811.0ESR1, KRAS, PIK3CA, CTNNB1
911.0PTEN, KRAS, CDKN2A, PIK3CA
1011.0KRAS, CDKN2A, PIK3CA, CTNNB1
11
Hide members
10.9MLH1, MLH3, MSH3
1210.9CTNNB1, CDH1, KRAS
13
Transcription Androgen Receptor nuclear signaling
Hide members
10.9CTNNB1, PIK3CA, PTEN
1410.9CTNNB1, PIK3CA, CDH1
15
Hide members
10.9CDH1, PIK3CA, CTNNB1
1610.9CDH1, PIK3CA, CTNNB1
1710.9CTNNB1, PIK3CA, CDH1
1810.9CTNNB1, CDKN2A, PTEN
19
Hide members
10.9ESR1, ESRRA, PGR
20
Hide members
10.9KRAS, CDKN2A, PIK3CA
2110.7CDH1, CTNNB1
2210.7CTNNB1, CDH1
2310.6MSH3
24
Hide members
10.6KRAS

Compounds for genes affiliated with Endometrial Carcinoma

About this section
Sources:
44Novoseek, 59Tocris Bioscience, 28IUPHAR, 11DrugBank, 24HMDB, 49PharmGKB, 2BitterDB
See all sources

Compounds related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 138)
idCompoundScoreTop Affiliating Genes
1progesterone44 59 28 11 2416.8MKI67, CDKN2A, CDH1, HOXA10, PGR, PTEN
2retinoic acid44 2413.7MKI67, CDKN2A, CDH1, MMP26, KRAS, PTEN
3testosterone44 59 11 2415.4PIK3CA, ESRRA, ESR1, PTEN, ARSH, PGR
4vegf4412.4MLH1, PIK3CA, CTNNB1, IFI27, MKI67, ESR1
5doxorubicin44 49 1114.3PIK3CA, ESR1, PTEN, MSH3, PGR, CDH1
6tyrosine4412.2PTEN, KRAS, ANG, HOXA10, CDH1, MKI67
7paclitaxel44 49 1114.2IFI27, CTNNB1, PIK3CA, PTEN, ESR1, MLH1
85fluorouracil4412.2CDKN2A, CDH1, PGR, KRAS, PTEN, ESR1
9tamoxifen44 49 28 1115.2ESRRA, PIK3CA, CTNNB1, MKI67, CDH1, PTEN
10paraffin4412.2ESR1, KRAS, PGR, CDH1, CDKN2A, MKI67
11cisplatin44 49 59 1115.2MSH3, CDH1, CDKN2A, IFI27, MKI67, MLH1
12genistein44 28 59 2 11 2417.0PTEN, ESRRA, ESR1, PGR, CDH1, IFI27
13arginine4412.0IFI27, PTEN, ARSH, CDH1, PIK3CA, MLH1
14steroid4411.9IFI27, ARSH, PIK3CA, MKI67, CDKN2A, HOXA10
15crcs4411.8CDH1, KRAS, PTEN, PIK3CA, CTNNB1, MLH1
16gefitinib44 49 1113.8KRAS, IFI27, CTNNB1, ESR1, PTEN, PIK3CA
175-aza-2deoxycytidine4411.8PTEN, ESR1, PGR, CDH1, CDKN2A, MLH1
18agar4411.8CDKN2A, PIK3CA, CDH1, PGR, PTEN, TDGF1P3
19fatty acid4411.7PTEN, MLH1, CTNNB1, IFI27, KRAS, ESRRA
20ly2940024411.7PTEN, PIK3CA, KRAS, CDH1, CTNNB1, IFI27
21trastuzumab44 49 1113.6IFI27, PTEN, PGR, PIK3CA, CTNNB1, ESR1
22estradiol44 11 2413.6ARSH, PTEN, MMP26, HOXA10, MKI67, PGR
23p0024411.6IFI27, CTNNB1, CDH1, KRAS, MKI67, MLH1
24mg 13244 5912.6IFI27, CTNNB1, CDH1, PTEN, ESR1, CDKN2A
25indole-3-carbinol4411.5IFI27, CTNNB1, CDH1, PTEN, ESR1
26diethylstilbestrol44 28 1113.5PGR, ESRRA, ESR1, PTEN, HOXA10
27vitamin d4411.5PTEN, ESR1, IFI27, CTNNB1, CDH1, KRAS
28irinotecan44 49 1113.5KRAS, CDH1, CDKN2A, MLH1, MKI67
29thymidylate4411.4CDH1, IFI27, MLH1, MKI67, CDKN2A
30docetaxel44 49 59 1114.4PIK3CA, CDKN2A, CDH1, ESR1, PGR
31sodium bisulfite4411.4CDKN2A, CDH1, MLH1, CTNNB1
32rapamycin4411.3PTEN, KRAS, CDH1, PIK3CA, CTNNB1, IFI27
33chi 24411.3MLH1, IFI27, MKI67, CDH1
34danazol44 11 2413.3ARSH, CDH1, PGR, ESR1
35o6-methylguanine4411.3MLH1, KRAS, CDKN2A, CDH1
36p000014411.3MLH1, CDH1, CDKN2A, MKI67
37steroidal4411.3PGR, IFI27, ESR1, ARSH
38bromodeoxyuridine4411.3CTNNB1, MLH1, MKI67, PIK3CA, IFI27
39sulindac44 1112.2IFI27, CTNNB1, MLH1, CDH1
40erlotinib44 49 1113.2CDH1, PIK3CA, KRAS, PTEN
41oxygen44 2412.2KRAS, IFI27, CDKN2A, MKI67, PTEN, ARSH
42estrogen4411.2HOXA10, ARSH
43quercetin44 59 11 2414.1PTEN, PIK3CA, CTNNB1, IFI27, ARSH
44folate4411.1MLH1, CDKN2A, CDH1, PGR, MKI67
4517beta-hydroxysteroid4411.0ARSH, MKI67, PGR, ESR1
46dihydrotestosterone44 28 11 2414.0ESR1, PGR, ARSH
47resveratrol44 59 11 2413.9PGR
48butyrate4410.9ARSH
49progestins4410.9ARSH, MKI67, ESR1, PGR
50cycloheximide4410.8HOXA10

GO Terms for genes affiliated with Endometrial Carcinoma

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Endometrial Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1nucleusGO:00563411.7CTNNB1, MLH1, MLH3, ANG, MKI67, CDKN2A
2internal side of plasma membraneGO:00989810.9PTEN, CDH1, CTNNB1
3chiasmaGO:00571210.9MLH3, MLH1
4MutLbeta complexGO:03239010.8MLH3, MLH1
5mismatch repair complexGO:03230010.7MLH1, MLH3
6Schmidt-Lanterman incisureGO:04322010.7PTEN, CDH1
7catenin complexGO:01634210.6CDH1, CTNNB1

Biological processes related to Endometrial Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mismatch repairGO:00629810.9MSH3, MLH3, MLH1
2reciprocal meiotic recombinationGO:00713110.9MSH3, MLH3, MLH1
3positive regulation of nitric-oxide synthase activityGO:05100010.7ESR1, KRAS
4regulation of protein localization to cell surfaceGO:200000810.6CTNNB1, CDH1
5cellular response to indole-3-methanolGO:07168110.4CTNNB1, CDH1

Molecular functions related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:00551512.6ESR1, CTNNB1, PIK3CA, MLH1, MLH3, ANG
2enzyme bindingGO:01989911.3CTNNB1, PGR, MSH3, PTEN, ESR1
3steroid bindingGO:00549611.0ESR1, ESRRA, PGR
4steroid hormone receptor activityGO:00370710.9PGR, ESRRA, ESR1
5guanine/thymine mispair bindingGO:03213710.8MSH3, MLH1
6single-stranded DNA bindingGO:00369710.8MLH1, MLH3, MSH3
7centromeric DNA bindingGO:01923710.7MSH3, MLH3
8mismatched DNA bindingGO:03098310.7MSH3, MLH3
9MutSalpha complex bindingGO:03240710.4MLH3, MLH1

Products for genes affiliated with Endometrial Carcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Endometrial Carcinoma

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet